Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-15

FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Allwell Health Inc)

View source ↗

Summary

The FDA approved a supplemental application for the generic olopatadine hydrochloride from Allwell Health Inc under ANDA209995. The action updates the approved …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)